Statements (22)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
inhaled corticosteroid
|
| gptkbp:approvalYear |
1996
|
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:brand |
gptkb:fluticasone_propionate
|
| gptkbp:compatibleWith |
acute asthma attacks
|
| gptkbp:contains |
gptkb:fluticasone_propionate
chlorofluorocarbon propellant |
| gptkbp:discontinued |
gptkb:Montreal_Protocol
environmental concerns |
| gptkbp:form |
metered-dose inhaler
|
| https://www.w3.org/2000/01/rdf-schema#label |
Flovent CFC
|
| gptkbp:indication |
maintenance treatment of asthma
|
| gptkbp:manufacturer |
GlaxoSmithKline
|
| gptkbp:market |
discontinued
|
| gptkbp:replacedBy |
gptkb:Flovent_HFA
|
| gptkbp:routeOfAdministration |
inhalation
|
| gptkbp:sideEffect |
cough
oral thrush hoarseness |
| gptkbp:usedFor |
asthma
|
| gptkbp:bfsParent |
gptkb:Flovent_HFA
|
| gptkbp:bfsLayer |
8
|